Suppr超能文献

人类抗原呈递细胞向抗原特异性异种小鼠T细胞呈递抗原。

Antigen presentation by human antigen-presenting cells to antigen-specific xenogeneic murine T cells.

作者信息

Yabu K, Yano A

出版信息

Microbiol Immunol. 1986;30(3):237-48. doi: 10.1111/j.1348-0421.1986.tb00939.x.

Abstract

Successful antigen presentation by xenogeneic human antigen-presenting cells (APC) to stimulate the proliferation of antigen-specific, keyhole limpet hemocyanin (KLH)-specific, ovalbumin (OVA)-specific, and purified protein derivative of Mycobacterium tuberculosis (PPD)-specific murine T cells was observed. Evidence indicating a direct cell interaction between antigen-specific murine T cells and xenogeneic human APC was given by experiments using antigen-specific murine T cell clones. The OVA-specific B10.S(9R) T cell line (9-0-A1) and PPD-specific B10.A(4R) T cell line (4-P-1) were stimulated by both xenogeneic human APC and murine APC from syngeneic or I-A compatible strains, while the PPD-specific human T cell line (Y-P-5) was stimulated by autologous human APC but not by murine APC. Anti-HLA-DR monoclonal antibodies (MoAb) blocked the xenogeneic human APC-antigen-specific murine T cell clone interaction. Thus, human xenogeneic APC can stimulate antigen-specific murine T cells through HLA-DR molecules in the same manner as syngeneic murine APC do through Ia molecules coded for by the I region of the H-2 complex, while murine APC failed to present antigen to stimulate human antigen-specific T cells.

摘要

观察到异种人抗原呈递细胞(APC)成功呈递抗原,以刺激抗原特异性、钥孔戚血蓝蛋白(KLH)特异性、卵清蛋白(OVA)特异性以及结核分枝杆菌纯化蛋白衍生物(PPD)特异性的小鼠T细胞增殖。使用抗原特异性小鼠T细胞克隆进行的实验表明,抗原特异性小鼠T细胞与异种人APC之间存在直接细胞相互作用。OVA特异性的B10.S(9R) T细胞系(9-0-A1)和PPD特异性的B10.A(4R) T细胞系(4-P-1)受到异种人APC以及来自同基因或I-A相容品系的小鼠APC的刺激,而PPD特异性的人T细胞系(Y-P-5)受到自体人APC的刺激,但未受到小鼠APC的刺激。抗HLA-DR单克隆抗体(MoAb)阻断了异种人APC与抗原特异性小鼠T细胞克隆之间的相互作用。因此,人异种APC能够通过HLA-DR分子刺激抗原特异性小鼠T细胞,其方式与同基因小鼠APC通过H-2复合体I区编码的Ia分子刺激小鼠T细胞的方式相同,而小鼠APC无法呈递抗原以刺激人抗原特异性T细胞。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验